glp-1 agonist weight loss comparison GLP-1R Agonists for Unlocking The Power of GLP-1

This challenge is multifaceted and cannot be attributed solely to diet, motivation, or physical activity levels

K.EgerodK

hypertension, type 2 DM, dyslipidemia) A meta-analysis of 22 trials involving over 17,000 patients determined that 50.2% and 17.5% of patients treated with GLP-1RAs (exenatide, semaglutide & liraglutide) experienced a weight loss of 5% and 10% compared to placebo, and that patients without type 2 diabetes achieved a significantly greater weight loss compared to those with diabetes (Vosoughi et al, 2022)

The majority of nausea, vomiting, and/or diarrhea events occurred during a dose increase and decreased over time

[1,2] This has important clinical implications